Psychiatric profile in rubinstein-taybi syndrome. A review and case report
- PMID: 19940543
- DOI: 10.1159/000260045
Psychiatric profile in rubinstein-taybi syndrome. A review and case report
Abstract
Background: The diagnosis of Rubinstein-Taybi syndrome (RTS) is primarily clinical and based on the characteristic phenotype that is often combined with a variety of somatic anomalies and psychiatric disorders.
Sampling and methods: In this paper, a review is presented of the psychiatric and behavioural aspects of RTS. This is illustrated with a case report.
Results: Behavioural aspects of about 150 patients are described, and include a variable degree of mental retardation, impulsivity, distractibility, instability of mood and stereotypies. In general, patients with RTS are described as sociable and friendly. Information about brain pathology is virtually absent. In about half of the cases, the syndrome is caused by a mutation or deletion of the CREB-binding protein (CBP) gene (16p13.3). The case report deals with an adult male who was referred for impulsivity and temper outbursts. A provisional diagnosis of atypical depression was made, and treatment with citalopram resulted in a remarkable amelioration of his mood and behaviour that persisted for more than 2 years (last observation).
Conclusion: Patients with undetected genetic syndromes do occur in clinical psychiatry, and the clinician has to consider such disorders in cases with disturbed development, dysmorphias and somatic comorbidity.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
Rubinstein-Taybi syndrome and CREBBP c.201 202delTA mutation: a case presenting with varicella meningoencephalitis.Genet Couns. 2009;20(3):255-60. Genet Couns. 2009. PMID: 19852432
-
Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum.Clin Dysmorphol. 2016 Oct;25(4):135-45. doi: 10.1097/MCD.0000000000000143. Clin Dysmorphol. 2016. PMID: 27465822
-
A boy with classical Rubinstein-Taybi syndrome but no detectable mutation in the CREBBP and EP300 genes.Genet Couns. 2011;22(4):341-6. Genet Couns. 2011. PMID: 22303793
-
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.J Med Genet. 2024 May 21;61(6):503-519. doi: 10.1136/jmg-2023-109438. J Med Genet. 2024. PMID: 38471765 Free PMC article. Review.
-
Rubinstein-Taybi syndrome: clinical and molecular overview.Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415. Expert Rev Mol Med. 2007. PMID: 17942008 Review.
Cited by
-
Benign and malignant tumors in Rubinstein-Taybi syndrome.Am J Med Genet A. 2018 Mar;176(3):597-608. doi: 10.1002/ajmg.a.38603. Epub 2018 Jan 23. Am J Med Genet A. 2018. PMID: 29359884 Free PMC article.
-
Rubinstein-Taybi syndrome: Clinical profile of 11 patients and review of literature.Indian J Hum Genet. 2012 May;18(2):161-6. doi: 10.4103/0971-6866.100751. Indian J Hum Genet. 2012. PMID: 23162289 Free PMC article.
-
Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression.J Biol Chem. 2012 Jul 13;287(29):24195-206. doi: 10.1074/jbc.M112.373936. Epub 2012 May 24. J Biol Chem. 2012. PMID: 22628545 Free PMC article.
-
Epigenetic mechanisms of Rubinstein-Taybi syndrome.Neuromolecular Med. 2014 Mar;16(1):16-24. doi: 10.1007/s12017-013-8285-3. Epub 2014 Jan 1. Neuromolecular Med. 2014. PMID: 24381114 Free PMC article.
-
Prospects for the development of epigenetic drugs for CNS conditions.Nat Rev Drug Discov. 2015 Jul;14(7):461-74. doi: 10.1038/nrd4580. Epub 2015 May 22. Nat Rev Drug Discov. 2015. PMID: 26000723 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
